Mechanical Abnormalities Detected With Conventional Echocardiography Are Associated With Response and Midterm Survival in CRT  by Doltra, Adelina et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 7 , N O . 1 0 , 2 0 1 4
ª 2 0 1 4 B Y T H E A M E R I C A N CO L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 4 . 0 3 . 0 2 2ORIGINAL RESEARCHMechanical Abnormalities Detected
With Conventional Echocardiography
Are Associated With Response and
Midterm Survival in CRT
Adelina Doltra, MD,* Bart Bijnens, PHD,y José M. Tolosana, MD,* Roger Borràs, BSC,* Malek Khatib, MD,*
Diego Penela, MD,* Teresa Maria De Caralt, MD, PHD,* María Ángeles Castel, MD, PHD,* Antonio Berruezo, MD, PHD,*
Josep Brugada, MD, PHD,* Lluís Mont, MD, PHD,* Marta Sitges, MD, PHD*ABSTRACTFro
Ba
CE
Un
(20
Clí
St.
MaOBJECTIVES Our aim was to identify “correctable abnormalities” using conventional grayscale and blood-pool Doppler
echocardiography and evaluate their ability to predict both response and midterm survival.
BACKGROUND Identiﬁcation of mechanical abnormalities that may be corrected with cardiac resynchronization
therapy (CRT) is useful for predicting echocardiographic response at 1-year follow-up.
METHODS A total of 200 CRT patients were included. Clinical evaluation and echocardiography were performed before
and after CRT to assess the presence of the mechanical abnormalities of interest (septal ﬂash, abnormal ventricular
ﬁlling, or exaggerated interventricular dependence). Response to CRT was deﬁned as a reduction in left ventricular (LV)
end-systolic volume (ESV) $15%. Four subgroups of extent of response were deﬁned: LVESV reduction >26.68%
(extensive remodeling); LVESV reduction 6.8% to 26.68% (slight remodeling); LVESV reduction <6.8% (no remodeling)
and clinical response; and LVESV reduction <6.8% without clinical response or the occurrence of death or heart
transplantation. Midterm cardiovascular survival was evaluated (mean follow-up 38  19 months).
RESULTS The presence of a correctable abnormality was independently associated with a better rate (odds ratio: 0.03
[95% conﬁdence interval (CI): 0.01 to 0.10], p < 0.001) and extent of response to CRT (n¼ 59 [96.7%] for the extensive
remodeling subgroup vs. n ¼ 53 [85.5%] for the slight remodeling subgroup vs. n ¼ 19 [47.5%] for the no remodeling
with clinical response subgroup vs. n ¼ 17 [45.9%] for the no remodeling without clinical response subgroup,
p ¼ 0.0001), as well as with increased midterm survival (hazard ratio: 0.11 [95% CI: 0.2 to 0.6]). Other independent
predictors included creatinine level and LV end-systolic diameter for response; New York Heart Association functional
class IV, creatinine, LV end-systolic diameter, and transmurality index for extent of response; and New York Heart
Association functional class IV for cardiovascular mortality.
CONCLUSIONS The presence of a correctable abnormality evaluated by conventional echocardiography is associated
with LV reverse remodeling and better survival at midterm follow-up. Clinical characteristics and myocardial viability also
have an inﬂuence. (J Am Coll Cardiol Img 2014;7:969–79) © 2014 by the American College of Cardiology Foundation.m the *Thorax Institute, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona,
rcelona, Spain; and the yICREA, Universitat Pompeu Fabra, Barcelona, Spain. This work was supported by grants from the
NIT program of the Centro de Desarrollo Tecnológico Industrial (cvREMOD project), the Agència de Gestió d’Ajuts
iversitaris i de Recerca (AGAUR) program of the Generalitat de Catalunya [2009-SGR-1104], the Spanish Society of Cardiology
10), and the Spanish Government [REDINSCOR RD06/0003/0008]. Dr. Doltra has received a personal grant from Fundació
nic. Dr. Mont is a consultant to, has received lecture fees, and has received research funding from Boston Scientiﬁc, Medtronic,
Jude, and Sorin. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
nuscript received November 11, 2013; revised manuscript received March 5, 2014, accepted March 6, 2014.
ABBR EV I A T I ON S
AND ACRONYMS
AV = atrioventricular
CMR = cardiac magnetic
resonance
CRT = cardiac
resynchronization therapy
DE = delayed enhancement
EF = ejection fraction
LV = left ventricle/ventricular
LVESD = left ventricular
end-systolic diameter
LVESV = left ventricular
end-systolic volume
NYHA = New York
Heart Association
SF = septal ﬂash
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970A lthough cardiac resynchronizationtherapy (CRT) is an established ther-apeutic option for patients with
advanced heart failure, the signiﬁcant rate
of nonresponders has also been repeatedly
demonstrated (1–3). This has led to intensive
research on dyssynchrony indexes to im-
prove response to CRT (4–6), which, despite
promising initial results, have failed to
show any beneﬁt when applied in a multi-
center setting such as the PROSPECT (Predic-
tors of Response to CRT) study (7). Recently,
a mechanism-focused approach has been
proposed for selecting candidates to CRT, in
which left ventricular (LV) dyssynchrony is
only 1 of the mechanisms assessed (8). This
approach would take into account all poten-tial mechanical abnormalities amenable to correction
with CRT, without relying on sophisticated and
poorly reproducible methods.SEE PAGE 980However, differences between studies in the rate
of CRT response may be partially explained by the
lack of a single parameter to deﬁne response (9).
Both clinical and echocardiographic criteria have
been used, making results from different studies
difﬁcult to compare. Although a reduction in left
ventricular end-systolic volume (LVESV) secondary
to CRT has been linked with survival (10), not all
patients remodel to the same extent, whereas others
may experience a clinical beneﬁt without reverse
remodeling (11).
The present study had 4 objectives: 1) to validate a
simple approach to recognize mechanical abnormal-
ities amenable to correction with CRT; 2) to compare
its predictive value against other proposed parame-
ters for CRT selection; 3) to investigate how this
approach relates to the extent of response; and 4) to
study whether it predicts survival.
METHODS
A total of 200 patients underwent CRT implantation
from January 2005 through December 2009. The in-
dications for implanting a CRT device were taken
from international guidelines: LV ejection fraction
(EF) #35%, QRS $120 ms, and New York Heart Asso-
ciation (NYHA) functional class II to IV despite
optimal medical therapy for at least 2 months. Can-
didates awaiting heart transplantation or with sig-
niﬁcant comorbidities that shortened life expectancy
were excluded. The study protocol was accepted by
our hospital’s ethics committee and conformed withthe Declaration of Helsinki. Informed consent was
obtained from all participants.
The study protocol included a baseline clinical and
echocardiographic examination, which was repeated
24 to 72 h after CRT implantation and at 12-month
follow-up. Clinical evaluation included NYHA func-
tional class assessment and a 6-min walk test. Addi-
tionally, mortality was assessed (see the following
text). In 82 patients, a baseline contrast-enhanced
cardiac magnetic resonance (CMR) was also
performed.
DEVICE IMPLANTATION. Patients received a CRT
pacemaker or a CRT deﬁbrillator, according to clin-
ical indications. A total of 141 patients (70.5%)
received a CRT deﬁbrillator, whereas 59 (29.5%)
received a CRT pacemaker. One lead was placed at
the right ventricular apex, another was implanted
through a distal cardiac vein into the posterolateral
wall (or in the most laterally located available vein if
necessary), and a third was placed in the right atrium
if the patient had sinus rhythm. The coronary sinus
was catheterized using a guiding catheter. All leads
were implanted transvenously.
ECHOCARDIOGRAPHY. A comprehensive echocardi-
ography-Doppler examination (Vivid 7, GE Healthcare,
Milwaukee, Wisconsin) was performed. The echocar-
diography examination included 2-dimensional
grayscale, color, and spectral blood-pool Doppler
and tissue Doppler imaging. Three cardiac cycles
were obtained for each acquisition. All studies were
stored and post-processed offline using EchoPAC
version 7.0.1 (GE Healthcare). LV end-diastolic
diameter and left ventricular end-systolic diameter
(LVESD) were measured from M-mode in the para-
sternal long-axis view, whereas LV end-diastolic
volume, LVESV, and EF were quantiﬁed by the
Simpson method.
The echocardiography examination also included
the evaluation of mechanical abnormalities amenable
to correction with CRT, as previously described (8).
Patients were divided into 5 subgroups, according to
the presence of these abnormalities (Figure 1):
 Septal ﬂash (SF), deﬁned as a fast contraction and
relaxation (inward/outward motion) of the septum
occurring during the isovolumetric contraction
period (within the QRS width), as visualized either
in 2-dimensional or M-mode images in the para-
sternal or 4-chamber views (SF—ﬁrst subgroup).
 Abnormalities in LV ﬁlling in the absence of SF,
including either the presence of fused E and A
waves with diastolic mitral regurgitation (long
atrioventricular [AV] delay—second subgroup) or a
truncated A-wave (short left AV delay—third
FIGURE 1 Correctable Abnormalities
(A) Example of septal ﬂash. In this M-mode echocardiography, the presence of an abnormal contraction and relaxation of the septum within
the QRS width, corresponding to a septal ﬂash, can be observed (arrows). (B) Example of E- and A-wave fusion (arrows) in a patient in the long
atrioventricular (AV) subgroup. (C) Example of short left AV delay; a truncated A-wave is shown (arrows). (D) Example of exaggerated
right–left interaction; an abnormal passive septal motion (arrows), different from the septal ﬂash, can be observed.
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971subgroup). The short left AV subgroup reﬂects a
delayed left atrial mechanical activation; in this
abnormality, a delayed interatrial conduction leads
to a late left atrium activation, delayed left atrial
contraction, and shortened emptying (12).
 Exaggerated right–left interaction without a
concomitant SF or an abnormal ﬁlling (fourth
subgroup), deﬁned as the presence of an abnormal
passive motion of the septum secondary to a
prolonged interventricular delay (difference be-
tween the left and right pre-ejection periods,
abnormal if >40 ms). Patients with prolonged
interventricular delay were only classiﬁed as
having exaggerated right–left interaction if neither
SF nor abnormalities were present and a visual
abnormal motion of the septum was observed,
that is, septal motion related to the contraction of
the free wall of the right ventricle and different
from the SF.
 The ﬁfth subgroup included those patients without
any of the aforementioned abnormalities.
The presence and correction of correctable abnor-
malities with CRT was evaluated early after theimplant (24 to 72 h after CRT implantation) and at
12-month follow-up.
Additionally, the LV ﬁlling time and the time dif-
ference of septal-to-lateral peak systolic velocities
assessed by Doppler tissue imaging were determined
(septal-to-lateral delay) (5). The LV ﬁlling time was
measured from the onset of the E-wave to the end of
the A-wave, and the R-R interval was measured to
calculate the percentage of ﬁlling time relative to
the cardiac cycle. The echocardiography examina-
tions were analyzed by a cardiologist blinded to
clinical and outcome data.
CARDIAC MAGNETIC RESONANCE. At 24 to 72 h
before CRT device implantation, CMR examinations
were performed with a 1.5-T Signa magnetic reso-
nance scanner (GEHealthcare). Delayed-enhancement
(DE) images were obtained 10 min after injecting
0.2 mmol/kg body weight gadodiamide (Omniscan,
GE Healthcare Buchler, Munich, Germany) using an
inversion recovery gradient echocardiography se-
quence. The DE images were analyzed by an investi-
gator blinded to clinical and echocardiography data,
using a 17-segment model. Each LV segment was
TABLE 1 Baseline Characteristics of the Studied Population
Age, yrs 67.37  9.17
Female 45 (22.5)
Ischemic etiology 79 (39.5)
NYHA functional class
II 50 (25.0)
III 131 (65.5)
IV 19 (9.5)
Medication
ACEI/ARB 190 (95.0)
Beta-blockers 161 (80.5)
Diuretics 164 (82.0)
Aldosterone antagonists 104 (52.0)
6-min walk test, m 275.92  130.32
Creatinine, mg/dl 1.28  0.52
QRS width, ms 169.29  30.38
LBBB 140 (70.4)
Atrial ﬁbrillation, % 67 (33.5)
LV end-diastolic volume, ml 259.5  84.4
LV end-systolic volume, ml 201.0  76.5
LV ejection fraction, % 24.0  6.0
LV end-diastolic diameter, mm 70.9  8.9
LV end-systolic diameter, mm 57.8  10.1
Septum-to-lateral delay, ms 67.5  49.2
LV ﬁlling time/RR, % 42.5  9.8
Values are mean  SD or n (%).
ACEI ¼ angiotensin-converting enzyme inhibitors; ARB ¼ angiotensin receptor
blockers; LBBB ¼ left bundle branch block; LV ¼ left ventricular; NYHA ¼ New
York Heart Association.
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972given a score from 0 to 4 according to the extent of
DE (0 ¼ no DE, 1 ¼ DE 1% to 25% of wall thickness,
2 ¼ 26% to 50%, 3 ¼ 51% to 75%, and 4 ¼ >75%). The
sum of all scores was divided by 17 to obtain the
transmurality index.
EXTENT OF RESPONSE. Considering the difﬁculty of
classifying CRT response as a dichotomous variable
and in order to analyze the extent of response ach-
ieved, we created 4 subgroups of patients with
different degrees of response at 1-year follow-up,
including clinical and echocardiographic evolution.
The decrease in LVESV at 12 months was divided in
tertiles to obtain reverse remodeling cutoff values.
The subgroups were constituted as follows: patients
in the ﬁrst tertile and no clinical response, patients in
the ﬁrst tertile and clinical response, patients in the
second tertile, and patients in the third tertile.
FOLLOW-UP. Patients were followed-up 12 months
after device implantation at the outpatient clinic.
Echocardiographic response to CRT was deﬁned as a
reduction of LVESV $15% at follow-up (11) in the
absence of death or heart transplantation. Clinical
responders were deﬁned as alive, without heart
transplantation, and with improvement of $20% in
the 6-min walk test or of at least 1 NYHA functional
class.
Mortality data were collected by reviewing outpa-
tient clinical history or by phone interviews with
relatives. Two cardiologists (J.M.T. and M.K.) re-
viewed the data and assigned the mode of cardiac
death, by consensus. Deaths were categorized as
cardiac, noncardiac, or unknown if the cause of death
could not be determined. Cardiac mortality was
deﬁned as sudden (not preceded by heart failure or
ischemic symptoms) or as the result of heart failure.
STATISTICAL ANALYSIS. Continuous variables are
presented as mean  SD. To compare means of 2
variables, we used the Student t test. Categorical
variables were expressed as total number (percent-
ages) and compared between groups using the chi-
square test. Logistic regression analysis was used
to study the effects of baseline characteristics to
evaluate the echocardiographic response at 1 year
(transversal endpoint). Multinomial logistic regres-
sion was used to evaluate the association between
baseline characteristics and extent of response. To
evaluate cardiovascular mortality during the follow-
up, we used Cox proportional hazards model anal-
ysis (longitudinal endpoint). Univariate regression
models were conducted for each of the potential
predictors. A p value <0.10 was used for the purpose
of screening covariates. Backward stepwise selection
algorithms were used for selecting the covariates intothe multivariate regression model. At each step, the
least signiﬁcant variable was discarded from the
model. Only covariates with a p value <0.10 remained
in the ﬁnal model. Odds ratios and hazard ratios with
95% conﬁdence limits were also calculated. A 2-sided
type I error of 5% was used for all tests. For the
analysis of predictors of echocardiographic response,
extent of response, and cardiovascular mortality,
correctable mechanical abnormalities were analyzed
as a binary variable (presence or absence of any of the
correctable mechanisms). Kappa statistic was used to
assess interobserver concordance. Statistical analysis
was performed using R software for Windows version
2.14.1 (R Project for Statistical Computing, Vienna,
Austria).
RESULTS
Table 1 summarizes the baseline characteristics of the
studied population. No patients were excluded based
on missing examinations or poor image quality. The
mean follow-up was 38  19 months. Of the 200 pa-
tients included, 105 (52.5%) responded to CRT at
1-year follow-up, according to echocardiographic
volume criteria, and 95 (47.5%) were nonrespon-
ders. During follow-up, 46 (23%) patients died: 30
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973(65.2%) of cardiovascular causes, 8 (17.4%) of
noncardiac causes, and 8 (17.4%) were recorded as
unknown cause of death. The 8 patients with a non-
cardiovascular cause of death and those 3 that were
lost to follow-up were excluded from mortality anal-
ysis. Only 1 death (in a patient that received a
CRT pacemaker) was due to an arrhythmic event,
whereas the remaining deaths were secondary to
heart failure. Eleven patients died in the ﬁrst
12 months after CRT implantation. Those patients
were classiﬁed as echocardiography nonresponders,
according to our pre-speciﬁed criteria. Those patients
were more often in NYHA functional class IV
(6 [54.5%] vs. 14 [7.4%], p < 0.0001), more often had
atrial ﬁbrillation (8 [72.7%] vs. 59 [31.2%], p ¼ 0.008),
had a signiﬁcantly lower LVEF (19.45  4.23% vs.
24.33  6.40%, p ¼ 0.013), and less often had a
correctable abnormality was (3 [27%] vs. 145 [76.7%],
p ¼ 0.001).
MECHANICAL ABNORMALITIES AND RESPONSE TO
CRT. A total of 122 patients (61%) corrected the
baseline abnormality with CRT. In most of them, the
correction was already present in the early echocar-
diogram (84%), whereas in the remaining 16%, an
early improvement was observed, followed by a res-
olution at 12 months.
Of 200 patients included, 106 (53%) presented with
SF at baseline; the rate of echocardiographic response
at 1 year in this subgroup was 80.2% (n ¼ 85), and CRT
corrected this abnormality in 93% of them. Of the 21
nonresponders, SF persisted in 7 (33.3%) at follow-up,Presence of a Septal Flash?
(2D or M-Mode)
Abnormalities i
Type of Filling Abnormality:
oNseY
seY
Long AV
N = 26 (13%)
38.5% Response
Septal Flash
N = 106 (53%)
80.2% Response
Short AV
N = 11 (5.5%)
63.6% Response
Truncated
A-wave
EA Fusion with
Diastolic MR
FIGURE 2 Rate of Echocardiographic Response and Presence of Any
The patients without any abnormality (others) or exaggerated right–left
patients with septal ﬂash respond. 2D ¼ 2-dimensional; AV ¼ atrioventand the 14 remaining patients had either a small SF at
baseline or an advanced disease (renal insufﬁciency
or severely dilated hearts). The long-AV group con-
tained 26 (13%) patients, with a response rate of
38.5% (10), and the abnormality was corrected in all of
them; of the 16 nonresponders, it was not corrected in
7 (43.8%). The short left AV subgroup had 11 patients
and a response rate of 63.6% (7); of the 4 non-
responders (36.4%), short left AV persisted in 3 (75%)
at follow-up. Only 5 patients (2.5%) were classiﬁed as
having an exaggerated right–left interaction; none of
them responded, despite improvement in interven-
tricular dyssynchrony in 3 (60%). The remaining
52 patients (26%) constituted the ﬁfth subgroup
(others), and 49 (94.2%) were nonresponders. Three
(5.8%) patients responded despite no mechanical
abnormality being identiﬁed at baseline (Figure 2).
To assess the interobserver reproducibility of
classifying patients according to the underlying
correctable abnormality, 40 random patients were
reanalyzed by a second observer blinded to the results
of the ﬁrst observer. The concordance between the 2
observers was very good (Kappa ¼ 0.76, p < 0.0001,
misclassiﬁcation error 0.17). When the concordance
was analyzed according to the presence of any
correctable abnormality versus no correctable abnor-
mality, we obtained also a very good interobserver
concordance (Kappa ¼ 0.78, p < 0.0001, misclassiﬁ-
cation error 0.07). Of note, there was an absolute
agreement between the 2 observers regarding the
presence of SF (Kappa ¼ 1, misclassiﬁcation error 0).n LV Filling?
Passive Motion of a
Dysfunctional Septum?
oN
Yes No
Exaggerated RLI
N = 5 (2.5%)
0% Response
Others
N = 52 (26%)
5.8% Response
of the Correctable Mechanical Abnormalities
interaction (RLI) are mainly nonresponders, whereas most of the
ricular; LV ¼ left ventricular; MR ¼ mitral regurgitation.
TABLE 2 Univariate and Multivariate Analysis for Prediction of Echocardiographic Response
Responders
(n ¼ 105)
Nonresponders
(n ¼ 95)
Univariate
OR (95% CI) p Value
Multivariate
OR (95% CI) p Value
Age, yrs 66.9  9.6 67.9  8.7 1.01 (0.98–1.04) 0.441
Female 31 (29.5) 14 (14.7) 0.41 (0.20–0.84) 0.011
Ischemic cardiomyopathy 35 (33.3) 44 (46.3) 1.73 (0.97–3.06) 0.061
Plasma creatinine, mg/dl 1.17  0.42 1.39  0.6 2.54 (1.33–4.85) <0.01 2.45 (1.06–5.65) 0.036
Atrial ﬁbrillation 27 (25.7) 40 (42.1) 2.11 (1.13–3.91) 0.017
QRS width, ms 173.5  31.5 164.8  28.7 0.99 (0.98–1.00) 0.044
LBBB 79 (75.2) 61 (64.2) 0.57 (0.31–1.05) 0.07
NYHA functional class IV 3 (2.9) 17 (17.9) 7.41 (2.10–26.18) <0.001
LVEF, % 24.5  6.4 23.6  6.4 0.98 (0.94–1.02) 0.315
LVEDD, mm 69.7  9.5 72.3  7.8 1.04 (1.00–1.07) 0.036
LVESD, mm 56.0  10.5 59.9  9.3 1.04 (1.01–1.07) <0.01 1.06 (1.02–1.10) <0.01
LVEDV, ml 251.7  86.1 268.1  82.0 1.00 (0.99–1.01) 0.172
LVESV, ml 193.4  74.4 209.4  78.4 1.00 (1.00–1.01) 0.143
LV ﬁlling time/RR, % 42.6  8.3 42.4  11.3 0.99 (0.96–1.04) 0.935
Septal-to-lateral delay, ms 65.2  46.6 70.0  52.0 1.00 (0.99–1.01) 0.583
Transmurality index 0.39  0.72 0.63  0.81 1.52 (0.83–2.76) 0.174
Presence of abnormality 102 (97.1) 46 (48.4) 0.03 (0.01–0.09) <0.001 0.03 (0.01–0.10) <0.001
Values are mean  SD or n (%). A total of 189 patients had echocardiographic follow-up at 12 months.
CI ¼ conﬁdence interval; LVEDD ¼ left ventricular end-diastolic diameter; LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼ left ventricular ejection fraction;
LVESD ¼ left ventricular end-systolic diameter; LVESV ¼ left ventricular end-systolic volume; OR ¼ odds ratio; other abbreviations as in Table 1.
Doltra et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 1 0 , 2 0 1 4
Correctable Abnormalities Underlying CRT Response O C T O B E R 2 0 1 4 : 9 6 9 – 7 9
974ECHOCARDIOGRAPHIC RESPONSE. The variables
analyzed are summarized in Table 2. Univariate pre-
dictors of echocardiographic response at 1 year were
female sex, NYHA functional class IV, atrial ﬁbrilla-
tion, presence of a correctable mechanical abnormal-
ity, baseline plasma creatinine level, LV diameters,
and baseline QRS. In the multivariate analysis, the1.0
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FIGURE 3 Predicted Prevalence of Echocardiographic Response Acc
Creatinine Level and LVESD
Although all variables are independent predictors of echocardiographic re
is very low in patients without any correctable abnormality, even in those
diameter (LVESD).independently related variables were the presence
of a correctable abnormality, creatinine, and LVESD
(Figure 3).
EXTENT OF RESPONSE. The decrease in LVESV at
12-month follow-up was divided into tertiles, obtain-
ing the following cutoff values: reduction of LVESVPr
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sponse, the probability of cardiac resynchronization therapy response
with a normal creatinine or a less dilated left ventricular end-systolic
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975>26.68% versus baseline; reduction of LVESV be-
tween 26.68% and 6.8%; and volumetric reduc-
tion <6.8% or LVESV increase at follow-up. The 4
subgroups of response were: 1) LVESV reduction
>26.68%; 2) LVESV reduction of 6.8% to 26.68%;
3) LVESV reduction <6.8% but with clinical response
(as previously deﬁned); and 4) LVESV reduction
<6.8% without clinical response or the occurrence of
death or heart transplantation at 1-year follow-up.
Table 3 and Figure 4 summarize our results. The
extent of response was signiﬁcantly related to NYHA
functional class IV, baseline plasma creatinine level,
baseline LVESD, CMR transmurality index, and the
presence of a correctable mechanical abnormality.
MIDTERM CARDIOVASCULAR SURVIVAL. In the
univariate analysis, baseline creatinine level, atrial
ﬁbrillation, NYHA functional class IV, LVEF, trans-
murality index, and the presence of a correctable
mechanical abnormality were associated with mid-
term survival. Only the presence of NYHA functional
class IV and a correctable mechanical abnormality
were independent predictors under multivariate
analysis (Table 4). Figure 5 shows the Kaplan-Meier
survival curves according to the presence of any
correctable mechanical abnormality and the impact of
its correction.
DISCUSSION
In the present study, a mechanical abnormality
correctable with CRT and easily recognized on stan-
dard echocardiographywas a key factor in determining
CRT response and was independently associatedTABLE 3 Association Between Baseline Characteristics and Extent of
Death or No Clinical Response
and LVESV Reduction <6.8%
(n ¼ 37 [18.5%])
Clinical R
LVESV Re
(n ¼
QRS, ms 161.2  30.5 168.
LBBB 23 (62.2) 27
Creatinine, mg/dl 1.5  0.7 1.3
Baseline LVESD, mm 59.1  8.4 61
Septal-to-lateral delay, ms 70.8  50.2 67
Transmurality index 0.3  0.5 0
LV ﬁlling time/RR, % 38.9  8.1 42.
NYHA functional class IV 10 (27) 7
Presence of abnormality 17 (45.9) 19
SF 5 (13.5) 12
ShAV 1 (2.7) 2
LAV 9 (24.3) 3
R-L 2 (5.4) 2
Values are mean  SD or n (%).
CRT ¼ cardiac resynchronization therapy; LAV ¼ long atrioventricular delay; R-L ¼ abno
other abbreviations as in Tables 1 and 2.with a high likelihood of response. Response is not
restricted to LV “dyssynchrony”; it includes other
correctable mechanical abnormalities. Some of these
(SF and short left AV) aremore strongly correlatedwith
response than others. Conversely, patients without
any of the mechanical abnormalities studied are most
likely nonresponders. Other results were that the
presence of a transmural scar determines the extent of
reverse remodeling, and the presence of a correctable
mechanical abnormality is associated with better
survival at midterm follow-up, provided that it is
corrected with CRT.
A MECHANISTIC APPROACH TO SELECT CRT
CANDIDATES. Besides technical limitations, another
explanation for the negative results of the PROSPECT
study may be that only “single parameters” to deﬁne
dyssynchrony were evaluated, each of them related
to only 1 aspect of “dyssynchrony.” We tested an
approach that was proposed initially by Parsai et al.
(8). This approach takes into account LV, AV, and
interventricular dyssynchrony. Similar to the ﬁndings
of Parsai et al. (8), our study demonstrated that the
presence of a correctable mechanical abnormality is
almost mandatory to obtain a positive response with
CRT. Patients without any of them were largely
nonresponders (1-year nonresponse rate 94.2%) and
had higher midterm mortality.
Nonetheless, mechanical abnormalities are not all
equally related to response: although the presence
of SF is strongly associated with response, patients
with a long AV or abnormal right–left interaction
are mainly nonresponders, as demonstrated by the
fact that from the 45.9% of nonresponders that hadResponse to CRT
esponse and
duction <6.8%
40 [20%])
LVESV Reduction of
6.8% to 26.68%
(n ¼ 62 [31%])
LVESV Reduction
>26.68%
(n ¼ 61 [30.5%]) p Value
6  25.6 171.2  33.3 173  30 0.081
(67.5) 45 (73.8) 45 (73.8) 0.57
 0.5 1.2  0.4 1.2  0.5 0.001
.1  9.8 58.5  11.5 54.3  8.9 0.005
 46.8 65.2  55 68  46.2 0.859
.8  1 0.5  0.6 0.3  0.7 0.043
5  12.1 42.8  9.7 43.5  8.4 0.285
(17.5) 0 (0.0) 3 (4.9) 0.001
(47.5) 53 (85.5) 59 (96.7)
(30.0) 37 (59.7) 52 (85.2) 0.0001
(5.0) 4 (6.5) 4 (6.6)
(7.5) 11 (17.7) 3 (4.9)
(5.0) 1 (1.6) 0 (0.0)
rmal right–left interaction; SF ¼ septal ﬂash; ShAV ¼ short left atrioventricular delay;
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FIGURE 4 Presence of Each Correctable Abnormality According to Subgroups of Extent of Response
The rate of patients with a correctable mechanical abnormality (speciﬁcally, septal ﬂash [SF]), progressively increases in the subgroups with
more reverse remodeling (RR). No remodeling: RR <6.8%, slight remodeling: RR 6.8% to 26.68%, extensive remodeling: RR >26.68%.
Abbreviations as in Figure 2.
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976a mechanical abnormality at baseline, only 29.4%
were having a SF, whereas the others were ﬁlling
abnormalities or exaggerated right–left interaction.
These ﬁndings suggest that the presence of SF is
the mechanical abnormality most easily amenableTABLE 4 Univariate and Multivariate Analysis for Prediction of Long
No CV Death
(n ¼ 159)
CV Death
(n ¼ 30)
Age, yrs 66.7  9.1 70.1  7.9
Female 36 (22.6) 7 (23.3)
Ischemic cardiomyopathy 60 (37.7) 13 (43.3)
Creatinine, mg/dl 1.2  0.5 1.5  0.7
Atrial ﬁbrillation 48 (30.2) 15 (50)
QRS width, ms 169.6  29.5 169.5  37.0
LBBB 110 (69.2) 20 (66.7)
NYHA functional class IV 11 (6.9) 7 (23.3)
LVEF, % 24.7  6.4 22.1  5.8
LVEDD, mm 70.6  9.1 70.8  7.5
LVESD, mm 57.5  10.6 57.3  8.3
LVEDV, ml 262.9  88.6 245.3  69.7
LVESV, ml 200.5  77.5 204.4  82.3
Filling time, % 42.7  9.9 38.9  7.3
Septal-to-lateral delay, ms 70.6  49.7 62.4  50.5
Transmurality index 0.5  0.7 1.1  1.1
Presence of abnormality 121 (76.1) 17 (56.7)
Values are mean  SD or n (%).
CV ¼ cardiovascular; HR ¼ hazard ratio; other abbreviations as in Tables 1, 2, and 3.to be corrected with CRT and most related to a
clear response. That suggests that although a me-
chanical abnormality seems to be necessary to
obtain CRT response, the probability of ﬁnally
achieving it is also determined by the underlying-Term CV Mortality With CRT
Univariate
HR (95% CI) p Value
Multivariate
HR (95% CI) p Value
1.04 (0.99–1.09) 0.078
0.88 (0.38–2.08) 0.772
1.45 (0.70–3.01) 0.315
2.58 (1.51–4.41) <0.001 3.26 (0.72–14.82) 0.127
2.82 (1.33–5.96) <0.01 0.16 (0.02–1.38) 0.095
0.99 (0.98–1.01) 0.897
0.94 (0.44–2.02) 0.868
4.93 (2.17–11.20) <0.001 6.03 (1.14–31.76) 0.034
0.93 (0.88–0.99) 0.033 0.94 (0.82–1.09) 0.426
1.00 (0.96–1.05) 0.909
1.00 (0.96–1.04) 0.971
1.00 (0.99–1.00) 0.384
1.00 (1.00–1.01) 0.640
0.96 (0.90–1.02) 0.225
1.00 (0.99–1.01) 0.563
2.07 (1.07–4.00) 0.031 1.60 (0.65–3.98) 0.307
0.37 (0.18–0.78) <0.01 0.11 (0.20–0.60) 0.011
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FIGURE 5 Kaplan-Meier Curves for Cardiovascular Mortality, Starting After CRT Implantation
(Left) Patients with a correctable mechanical abnormality (A) had a more favorable outcome than those without an abnormality (others, O).
(Right) Patients with a corrected mechanical abnormality (CA) had a better survival than those without an abnormality (O) and those with a
noncorrected mechanical abnormality (NCA). CRT ¼ cardiac resynchronization therapy.
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977mechanical abnormality and myocardial substrate.
Other studies have also demonstrated the ability of
abnormal septal motion to predict CRT response.
Voigt et al. (13) referred to it as apical rocking, and
demonstrated a high rate of response when it was
present. Also, low-dose dobutamine increased the
amplitude of apical rocking, which correlated
strongly with reverse remodeling and survival (14),
Additionally, Risum et al. (15) differentiated a
classic SF pattern (characterized by an early con-
traction of the septum or anteroseptal wall and
early pre-stretching and late contraction of the
opposite ventricular wall) from a nonclassical
pattern, and demonstrated that the classical pattern
was highly predictive of response. Our data add
more evidence suggesting a link between SF and
high probability of response to CRT and addition-
ally emphasize the importance of taking into ac-
count other mechanical abnormalities amenable to
being corrected with CRT such as the case of AV
ﬁlling abnormalities.
In a multivariate analysis, we demonstrated that
the presence of these mechanical abnormalities is an
independent predictor of echocardiographic response
and midterm cardiovascular mortality, along with
creatinine level and LVESD (reﬂecting “severity” of
the disease). The main advantage of the proposed
approach is that it would prevent the implant of
a CRT device in patients without any mechanicalabnormality and, thus, a strong probability of non-
response (94.2%).
EXTENT OF RESPONSE. When the patients in our
population were divided according to the degree
of response achieved with CRT, the presence of a
mechanical abnormality was also a signiﬁcant dif-
ference between subgroups; other signiﬁcant dif-
ferences included transmurality index, NYHA
functional class IV, baseline creatinine level, and
baseline LVESD. Interestingly, the transmurality in-
dex was not signiﬁcantly related to CRT response
when response was analyzed dichotomously (i.e.,
based on LVESV reduction $15%). According to our
results then, transmurality index would determine
not the response per se, but rather, the extent of
response. A patient would be able to respond to CRT
if some degree of dyssynchrony was present (not
necessarily at the LV level), but the extent of
response achieved would be determined by the
amount of myocardium that can actually be
remodelled. This is in concordance with previous
reports indicating a lesser extent of reverse remod-
eling in CRT patients with ischemic cardiomyopathy
(16–18).
INFLUENCE ON SURVIVAL. The presence of a
correctable mechanical abnormality was indepen-
dently predictive of a better outcome at midterm
follow-up, with reduced cardiovascular mortality at
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978multivariate analysis. Prior studies have also demon-
strated a relationship between dyssynchrony and
outcome, but in contrast to the present work, had
analyzed only 1 aspect of dyssynchrony (19). Our re-
sults indicate that the presence of a correctable me-
chanical abnormality not only detects patients with a
higher probability of reverse remodeling, but also has a
real impact on survival. However, the extent of
response will be variable depending on other baseline
parameters such as myocardial substrate (viability),
underlying disease (renal insufﬁciency), and clinical
status.
STUDY LIMITATIONS. In the present study, as in
previous reports (20), the division between the
different subgroups of extent of response is arbitrary;
therefore, slightly different results might be obtained
using other cutoff values. However, changing the
threshold for an absolute dichotomous echocardio-
graphic response to CRT could produce the same
effect. In our clinical practice, not all patients beneﬁt
equally from CRT, and we believe studying subgroups
of extent of response is more informative than a
simple cutoff value.
CMR was not performed in the whole cohort.
Additionally, we did not quantify scar extent, which
would give more precise information on the rela-
tionship between scar and response, and we did not
analyze the effect of scar location and the relation-
ship of scar with the other factors of response.
Therefore, conclusions regarding the effect of scar on
(the amount of) CRT response should be further
investigated in larger studies. Additionally, we did
not perform a dobutamine challenge to our patients,
which has been used to depict myocardial contractile
reserve (21) and also to induce a potentially correct-
able SF that is subtle at rest and might be mis-
diagnosed (14,22). Finally, we are aware that the
reproducibility of the outcome measurements (i.e.,
LV volumes and 6-min walking test performance)
might be imperfect. However, even when we con-
sidered several groups of combined and progressive
responses, we could ﬁnd a strong relationship be-
tween response and the presence of a correctableabnormality, supporting our hypothesis and the val-
idity of this approach (23,24).
The number of mortality events at follow-up in our
study population was relatively small; this small
number of events constitutes a limitation in the sur-
vival multivariate analysis, and should be taken into
account when interpreting its results. Also, we did
not include appropriate implantable cardioverter-
deﬁbrillator therapies and shocks in the mortality
analysis. Different results could have been obtained
had this variable been included.
The presence of reverse remodeling may have
contributed to the correction of baseline abnormal-
ities, especially in those few patients in which
correction was mainly observed at 12-month echo-
cardiogram. However, even in those patients, an im-
mediate abnormality improvement was observed,
and therefore, the correction can be mostly attributed
to CRT. Finally, the number of patients having me-
chanical abnormalities other than SF was small.
Conclusions regarding those subgroups should also
be taken with caution and warrant conﬁrmation in
further larger studies.
CONCLUSIONS
Our study supports the easy evaluation of a poten-
tially correctable mechanical abnormality with con-
ventional echocardiography that would lead to more
adequate selection of candidates to CRT. The pres-
ence of a correctable abnormality is associated with
LV reverse remodeling and survival at midterm
follow-up. However, the extent of LV reverse re-
modeling is also inﬂuenced by other factors related
to the clinical evolution of the disease (NYHA func-
tional class) and the status of the underlying
myocardium (myocardial viability) that should be
taken into account when selecting potential candi-
dates for CRT.
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